REGENERON PHARMACEUTICALS, INC.
REGENERON PHARMACEUTICALS, INC. is an Investment Adviser institutional filer with the SEC under CIK 872589, reporting 3 portfolio positions, with 13 historical 13F filings on file. Most recent reporting period: 2026-06-30.
A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).
- Sector: Pharmaceutical Preparations
- State of incorporation: NY
- Filing type: 13F-HR
- Latest reporting period: 2026-06-30
- Last filed: 2026-08-07
Top 3 portfolio positions
The largest reported holdings in REGENERON PHARMACEUTICALS, INC.'s most recent 13F filing, ranked by reported market value.
/